Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose

BACKGROUND: Heart failure (HF), the leading cause of morbidity and mortality in the US, affects 6.6 million adults with an estimated additional 3 million people by 2030. More than 50% of HF patients have heart failure with preserved left ventricular ejection fraction (HFpEF). These patients have imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierce, Janet D., Mahoney, Diane E., Hiebert, John B., Thimmesch, Amanda R., Diaz, Francisco J., Smith, Carol, Shen, Qiuhua, Mudaranthakam, Dinesh Pal, Clancy, Richard L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879598/
https://www.ncbi.nlm.nih.gov/pubmed/29606104
http://dx.doi.org/10.1186/s12872-018-0796-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879598/
https://www.ncbi.nlm.nih.gov/pubmed/29606104
http://dx.doi.org/10.1186/s12872-018-0796-2

Ejemplares similares